Regulus Therapeutics
Earnings Surprise
Analysts estimated RGLS earnings of $-0.25 per share this quarter (Q1). RGLS's actual earnings were $-0.15 per share.
RGLS EPS surprise of 39.98%Analysts estimated RGLS earnings of $-0.21 per share this quarter (Q4). RGLS's actual earnings were $-0.20 per share.
RGLS EPS surprise of 6.63%Analysts estimated RGLS earnings of $-0.17 per share this quarter (Q3). RGLS's actual earnings were $-0.21 per share.
RGLS EPS surprise of -21.11%Analysts estimated RGLS earnings of $-0.15 per share this quarter (Q2). RGLS's actual earnings were $-0.17 per share.
RGLS EPS surprise of -13.64%Analysts estimated RGLS earnings of $-0.23 per share this quarter (Q1). RGLS's actual earnings were $-0.29 per share.
RGLS EPS surprise of -27.75%Analysts estimated RGLS earnings of $-0.40 per share this quarter (Q3). RGLS's actual earnings were $-0.40 per share.
RGLS EPS surprise of -1.14%Analysts estimated RGLS earnings of $-0.40 per share this quarter (Q3). RGLS's actual earnings were $-0.40 per share.
RGLS EPS surprise of -1.14%